silybin has been researched along with celecoxib in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choe, JH; Hur, SM; Kim, JH; Kim, JS; Kim, S; Kim, SH; Kim, WW; Lee, JE; Lee, SK; Nam, SJ; Yang, JH | 1 |
Dai, Y; Meng, J; Wan, X; Yan, S; Zhang, Y | 1 |
3 other study(ies) available for silybin and celecoxib
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Butadienes; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Down-Regulation; Humans; MAP Kinase Kinase Kinases; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Nitriles; Phytotherapy; Protein Kinase Inhibitors; Pyrazoles; Seeds; Silybin; Silybum marianum; Silymarin; Sulfonamides; Tetradecanoylphorbol Acetate | 2009 |
Visualization of network target crosstalk optimizes drug synergism in myocardial ischemia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Celecoxib; Cells, Cultured; Curcumin; Cyclooxygenase 2 Inhibitors; Drug Synergism; Drug Therapy, Combination; Humans; Molecular Targeted Therapy; Myocardial Ischemia; Myocytes, Cardiac; Pyrazoles; Rats; Rats, Sprague-Dawley; Silybin; Silymarin; Sulfonamides | 2014 |